Bacterial Etiology of Sputum from Tuberculosis Suspected Patients and Antibiogram of the Isolates

doi:10.21203/rs.3.rs-36012/v1

Download PDF

Research note

Bacterial Etiology of Sputum from Tuberculosis Suspected Patients and Antibiogram of the Isolates

https://doi.org/10.21203/rs.3.rs-36012/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 10 Nov, 2020

Read the published version in BMC Research Notes →

You are reading this older preprint version

Read the latest preprint version →

Objective The current study aims to explore the bacteriology of sputum of tuberculosis (TB) suspected patients. A cross-sectional study was carried out in the sputum samples of 150 TB suspected patients visiting District Public Health Office, Bharatpur, Nepal. The samples were subjected to cultural, microscopic and biochemical analyses for the identification of the isolates. In addition, antibiotic susceptibility tests were carried out with a special focus on ESBL and MBL production following Clinical and Laboratory Standard Institute guidelines.

Results

Bacterial growth was recovered in 47% (71/150) of the TB suspected patients of which 12.66% (19/150) had pulmonary TB infection. Streptococcus spp. (9%) and Pseudomonas aeruginosa (9%) were the most frequently isolated bacteria. Enterobacteriaceae accounted for 35% of the total isolates. Occurrence of bacterial pathogens was more in males (69%) than in females (31%).The incidence of bacterial pathogen was seen associated with the gender of the patients and with the TB infection (p<0.05) but independent with the age of the patients and HIV infection(p>0.05). Tetracycline was effective against Streptococcus spp. whereas gentamicin was effective against Bacillus spp. Imipenem and co-trimoxazole were effective drugs for Gram-negative isolates. Among 83 isolates, 35 were multi-drug resistant, 9 were ESBL producers and 4 were MBL producers.

Plastic & Reconstructive Surgery

Applied & Industrial Microbiology

Tuberculosis

Respiratory tract infection

MDR

Sputum

Respiratory Tract Infections (RTIs) are the most frequently reported among human infections, out of which Lower Respiratory Tract Infections (LRTIs) accounts for almost 90% [1]. Upper Respiratory Tract Infections (URTIs) are commonly caused by viruses than bacteria and fungi but LRTIs are more commonly caused by bacteria and less by fungi and viruses. These diseases directly result in about 7 million deaths annually [2]. As population evolve and immune-compromising conditions become more frequents, many more people are at the risk of LRTIs [3]. The HIV pandemic has even worsened morbidity and mortality due to LRTIs which causes about 70% of illnesses in AIDS patients [4]. To differentiate Tuberculosis (TB) from other LRTIs such as bacterial pneumonia is an important clinical challenge in developing countries, and failure to differentiate TB from other LRTIs may result in poorer health outcomes which may lead in high mortality rate [5]. Tuberculosis is the most feared health issue in developing countries like Nepal. Emergence of bacterial coinfections along with the development of antimicrobial resistance complicates the TB-treatment process [6].

Several studies carried out world-wide report that the potent pathogens of RTIs are Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Bacillus spp., Moraxella catarrhalis, Streptococcus pyogenes and some other enteric Gram-negative rods such as Salmonella choleraesuis, Citrobacter koseri [7, 8]. Most of these bacteria are normal flora of the human respiratory tract. So it is clear that most of the time, the infection is initiated by normal flora and secondary infection from other invader bacteria [9].

Gram-negative bacteria, especially Enterobacteriaceae are increasing their antibiotic resistance ability [10]. Gram-positive cocci such as S. aureus and Streptococcus sppare also evolving as multi-drug resistant (MDR) [11]. Bacterial co-infection in TB patients is regarded as one of the main causes of mortality and morbidity and this will always increase since bacteria are evolving to resist antibiotics. To the best of our knowledge, no any attempts have been made yet exploring the bacterial composition of sputum of TB suspected patients in Nepal. Hence, this study was designed to explore the bacteriological spectrum of sputum from the patients suspected of tuberculosis and determine the antibiotic susceptibility pattern of the isolates.

Study design, area and sample population

This was a descriptive cross-sectional study enrolling 150 TB suspected patients who visited District Public Health Laboratory (DPHO), Bharatpur, Chitwan over 2 months from January to February, 2020. The patients were asked to collect early morning sputum sample in a clean dry and leak-proof container and bring it cautiously to DPHO laboratory.

Sample collection and transport

Immediately after collecting the sputum, each sample was observed microscopically for the presence of AFB bacilli by Ziehl-Neelsen staining at DPHO laboratory. The samples were then transported aseptically to the Microbiology laboratory of Birendra Multiple Campus for bacteriological investigations within half an hour. A little of each AFB positive sample was left at the DPHO laboratory for further analysis by Genexpert method.

Culture and identification of the isolates

The methodology was followed according to a similar study done by Ngekeng [7]. A loopful of the uncentrifuged sample was streaked over Chocolate agar, Blood agar, MacConkey agar and XLD agar (Hi-Media, India) under laminar airflow conditions. Duplet culture was performed to ensure that bacterial growth was not from contamination of media. Blood agar was incubated at anaerobic condition and Chocolate agar, MacConkey agar and XLD agar were incubated at the aerobic condition for 24 h at 37ºC. Bacterial colonies were further subcultured until pure culture was obtained. Identification of bacterial isolates was done based on their morphological and biochemical characteristics [12].

Antibiotic susceptibility testing

The bacterial isolates were subjected to Antibiotic Susceptibility Test (AST) by modified Kirby Bauer's disc diffusion method following CLSI guidelines (2016) [13]. Altogether, 17 different commonly used antibiotics procured from Hi-Media, India were used for testing. AST was performed for all the isolates and the zone of inhibition was measured and interpreted following CLSI guidelines (2016) [13]. In case of Bacillus spp., AST was performed as suggested by Charteris et al [14]. Resistance to at least one drug from 3 different antibiotics of different structural classes was considered MDR as described elsewhere [15].

Screening of ESBL and MBL producers

Primary screening of ESBL producers was done by using ceftazidime (CAZ) (30µg) and cefotaxime (CTX) (30µg) disks (Hi-Media, India). If the zone of inhibition was 22mm for CAZ and/or 27mm for CTX, the isolate was considered a potential ESBL-producer as recommended by NCCLS [16]. Combination disk method [17] was used to confirm ESBL-producing isolates in which CTX and CAZ (30µg), alone and in combination with clavulanic acid (CA) (10µg) were used. An increase in ZOI of 5mm for either antimicrobial agent tested in combination with CA versus its zone when tested alone confirmed ESBL [13].

Imipenem resistant Gram-negative isolates were selected for the further detection of MBL production by disc potentiation method as previously described [29]. Briefly, bacterial isolates (adjusted to 0.5 McFarland turbidity standards) were aseptically swabbed on Mueller-Hinton (MH) agar plates and standard antibiotic disks of imipenem (10 µg) and meropenem (10 µg) impregnated with EDTA (1 µg) was aseptically placed on MH agar plates. Supplementary imipenem (10 µg) and meropenem (10 µg) disks without EDTA were also placed alongside the antibiotic disks impregnated with the chelating agent (EDTA) at a distance of 20 mm apart. All plates were then incubated at 30°C for 18-24 h and zone of inhibition were recorded after incubation. A difference of ≥ 7 mm between the zones of inhibition of any of the carbapenem disks with or without the chelating agents was considered as metallo β-lactamase production [29].

Quality control

Each batch of media and reagents was subjected to sterility and performance testing. During antibiotic susceptibility test, quality control was done using the control strains of E. coli ATCC 25922.

Data management and statistical analysis

All the raw data obtained in this study were tabulated in SPSS V.20 and Chi-square test was performed. P ≤ 0.05 was assigned as significant.

Distribution of bacteria in sputum

Among the 150 sputum samples, only 71(47.33%) showed the bacterial growth, out of which 61(85.92%) had monomicrobial growth and 10(14.09%) had polymicrobial growth. The most common bacteria were Streptococcus spp. and Pseudomonas aeruginosa, both isolated in 14(9.33%) samples followed by S. aureus 12(8.00%) and S. pneumoniae 10(6.67%). Enterobacteriaceae isolates were obtained in 21 instances, among which K. pneumoniae were 13(8.67%), E. coli were 4(2.67%) and Salmonella spp. and C. koseri were both found in 2(1.33%) cases (Fig. 1).

Association of different variables with bacterial isolation

Among 150 study participants, only 5 (3.33%) people were HIV-infected of which 4 (80.00%) showed the bacterial growth. The incidence of bacterial growth was not found associated with HIV infection (p>0.05). Gender-wise, 54.44% of growth was recovered from males and 36.67% from females and recovery of bacteria in sputum sample was found associated with gender (p<0.05). Higher prevalence of LRTIs was found in the age group 31-45 and 46-60 accounting for 14(56.00%) and 29 (55.76%) of growth respectively. However, no statistical association was observed between bacterial incidence with the age group (p>0.05). Among 150 TB suspected patients, only 12.67% were confirmed to have tuberculosis of which 18 (94.74%) showed the growth of bacteria. A very high degree of association was noted between the incidence of bacterial pathogens and tuberculosis infection (p<0.05). Current smokers were found to be more vulnerable to bacterial infection as compared to non-smokers and past smokers as 65.79% isolates were recovered from the current smokers. A strong association was observed statistically between the smoking habit and bacterial growth (p<0.05). Habit of alcohol consumption was also noted to contribute significantly in bacterial infection as 78.57% alcohol consumers showed the growth of bacteria (p<0.05) (Table1).

Table 1

Distribution of bacterial growth with various attributes
Attributes	Sample size	Growth Rate	Odds Ratio (95% CI)	p- value
Gender
Male	90	54.44%	2.06(1.06-4.03)	0.033
Female	60	36.66%	1
Age Group
0-15	9	4.44%	1
16-30	29	37.93%	0.76(0.17-3.47)	0.727
31-45	25	56.00%	1.59(0.34-7.37)	0.553
46-60	52	55.76%	1.58(0.38-6.54)	0.531
60+	35	37.14%	0.74(0.17-3.25)	0.689
Smoking
Yes	38	65.79%	2.65(1.16-6.04)	0.020
No	69	42.03%	1
In Past	43	39.53%	0.9(0.42-1.96)	0.794
Alcohol Consumption
Yes	28	78.57%	5.84(2.14-15.97)	0.000
No	83	38.55%	1
In Past	39	43.59%	1.23(0.57-2.67)	0.597
TB Infection
Yes	19	94.74%	26.49(3.43-204.46)	0.001
No	131	40.46%	1
HIV Infection
Yes	5	80.00%	4.66(0.51-42.68)	0.174
No	145	46.21%	1

Antibiotic susceptibility pattern of the isolates

Antibiogram of the Streptococcus spp. revealed that tetracycline was the most effective drug with 86.33% sensitivity, whereas gentamicin was the least effective with 14.30% sensitivity. All the Enterobacteriaceae isolates were resistant to amoxicillin/clavulanic acid whereas sensitive to co-trimoxazole. P. aeruginosa was sensitive to some of the second-line antibiotics whereas amikacin was completely resisted by it. (Details of antibiotic susceptibility testing can be viewed in Table S1 and S2. Among the total 81 bacterial isolates, 45 were multi-drug resistant (MDR). Streptococcus spp. was predominant (26.67%) among the MDR isolates (Fig. 1). To confirm ESBL producers, 14 presumed ESBL producing isolates were tested among which 9(25.71%) isolates were confirmed ESBL producers, K. pneumoniae 4(44.44%) being the predominant one. On performing combined disk test of 10 presumptive MBL isolates, only 4(40.00%) were confirmed as MBL producers of which 2 isolates were P. aeruginosa and 1 each of K. pneumoniae and E. coli (Table 2).

Table 2

Frequency of ESBL and MBL isolates
	ESBL		MBL
Organisms	Presumptive	Confirmatory(Combination Disk Method)	Presumptive	Confirmatory(Combined Disk Test)
P. aeruginosa	4	2(50.00%)	5	2(40.00%)
K. pneumoniae	7	4(57.14%)	3	1(33.33%)
E. coli	2	2(100.00%)	2	1(50.00%)
Salmonella spp.	1	1(100.00%)	0	0
Total	14	9(64.29%)	10	4(40.00%)

This study documented bacterial growth in the sputum of 47.33% (71/150) tuberculosis-suspected individuals. A Cambodian study also revealed similar result with 43.79% bacterial growth [5]. On the other hand, report from a Nigerian study showed a growth rate of around 61.37% [7]. Such a high degree of variation may be due to the different methods employed for the collection and processing of the samples in different places. In the current study, P. aeruginosa was the most predominant bacterial isolate recovered in 9.33% of the total sample. A similar result was found in a research done in Pakistan, where the prevalence of P. aeruginosa was11.96% [18]. The frequent incidence of P. aeruginosa in the sputum may be owing to their ability to colonize a wide range of ecological niches, such as air polluting agents, animal hosts and humans [19]. S. pneumoniae was isolated in 6.67% sputum samples in our study, but in most of the other similar world-wide studies, S. pneumoniae has been reported as the chief isolate [7, 20, 21]. In the present study, the prevalence of K. pneumoniae was 8.67% in the sputum samples. This rate is almost similar to the study conducted by Hasan et al. who observed a 10.8% prevalence of K. pneumoniae [22]. Prevalence of Staphylococcus aureus was 8.00% in this study, similar to Ngekeng’s study where it was 6.5% [7]. Incidence of Streptococcus spp., S. aureus and K. pneumoniae may be due to their distribution in the respiratory tract where they remain as opportunistic pathogens and may infect when patient’s immune system is compromised. We observed a prevalence of 6.67% for Bacillus spp. which is exactly similar to the study carried out in Iraq [22].

Prevalence of LRTIs was found greater in male (54.44%) than in female (36.67%). A similar study in Nigeria showed LRTIs was 54.80% in male and 67.10% in female [7]. Gender has varied impact on bacterial incidence as some studies show higher infection in females [21] while others show more in males [20]. Higher growth reported among men in our study might be due to lifestyle factors like smoking and alcohol consumption [7]. Higher prevalence of infection was seen in the age group 31-45 (56.00%) and 46-60 (55.76%). A similar study by Attia et al. showed the age group 38-65 (53.00%) as the most susceptible for LRTIs [5]. Age group of 46-60 are under more threats of being infected as people in this age group have declined level of immunity and their exposure to the environment is high [23]. In our study, 12.67% of the suspected patients were confirmed to have TB. This rate is similar to the study carried by Ngekeng et al. where it was 13.79% [7]. Tuberculosis infection was significantly associated with bacterial co-infection (p< 0.05). As immunity decreases during active TB, bacteria attack the immune-compromised person more easily as compared to healthier person [24]. In the current study, only 5 (3.33%) people were HIV-infected patients and no any association was observed between having HIV with bacterial incidence (p>0.05). This study accounted 65.79% bacterial growth from the smokers. This rate is higher than the study carried out by Ngekeng where it was 61.10% [7]. In a study, Attia and his colleagues found the staggering rate of 81.81% where a significant association between smoking and bacterial growth was not noted [5]. The rate of bacterial growth among alcohol consumers was 78.57% in this study, which is 53.9% in a study carried out in Nigeria [7]. Higher prevalence of bacterial growth in those who were habitual to smoking and alcoholism may be because smoking and alcoholism usually increase risk to lower respiratory tract infections by diminishing mucosal immunity [20].

The present study documented 55.56% MDR isolates. This rate is similar to a study carried out in Kathmandu with 47.57% prevalence of MDR isolates [25]. Another study in the same city also showed the same prevalence of MDR isolates (57.50%) [26]. Besides, 26.00% of Gram-negative isolates were ESBL producers in this study, K. pneumoniae being the top contributor. This rate is similar to the one carried out by Pokhrel and his colleagues where the rate was 24.27% with the same organism being the dominant one. This study also documented 11.43% of Gram–negative isolates as MBL producers. A study carried out in LRTIs patients in Nepal Medical College revealed that 5.80% isolates were MBL producers [26]. Another study in Nigeria accounted 4.70% Gram-negative isolates as MBL producer [27].

The current study reveals a bacterial prevalence of 47.33% from the sputum of TB-suspected patients. Out of 150 study subjects, 12.66% (19/150) had pulmonary tuberculosis. Discovery of multidrug resistant bacteria including EBL and MBL producers in the sputum of patients with TB and LRTIs is worrisome and concerned authorities should be more alert to abate their incidence and dissemination.

The present study lacks the molecular characterization of the isolates. Also, it does not include other important LRTIs causing bacteria such as H. influenzae and M. catarrhalis. Only bacterial isolates were considered, and fungus and viruses were not included in the study.

TB: Tuberculosis

ESBL: Extended spectrum beta-lactamase

MBL: Metallo beta-lactamase

MDR: Multidrug resistant

AST: Antibiotic susceptibility test

CLSI: Clinical and laboratory standards institute

ZOI: Zone of inhibition

Ethics approval and consent to participate

As the sampling process involves human volunteers, ethical consent was required prior to executing the research work. Ethical clearance was taken from the National Health Research Council (NHRC) (Ref No. 1464). Patients were recruited into after obtaining written informed consent.

Consent of publication

Not applicable

Availability of data and materials

All the data obtained during this study are available within the article.

Competing interests

The authors declare that they have no competing interests.

Funding

No specific funding was available for this study.

Authors’ Contribution

RSR and SA conceived the concept and design of this study. RSR, BD, BL and KKD performed experimental work. RSR, SS, SA, SK and SCK analyzed the data and prepared the final draft of the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We thank all the patients who provided us with sputum sample for this study. We would like to thank all the staffs of DPHO, Bharatpur. We are also grateful to all the staffs of Microbiology Laboratory of Birendra Multiple Campus, Bharatpur, Chitwan.

Thomas M, Bomar P, Koutsothanasis GA. Upper Respiratory Tract Infection. In: StatPearls Publishing. Treasure Island: StatPearls Publishing; 2019. https://www.ncbi.nlm.nih.gov/books/NBK532961/.
Akan OA, Ahmed K, Nagatake T, Ozyilmaz E, Gulhan M. Major bacteria of community-acquired respiratory tract infections in Turkey. Jpn J Infect Dis. 2005;58:50–2.
Carroll KC. Laboratory Diagnosis of Lower Respiratory Tract Infections Controversy and Conundrums. J Clin Microbiol. 2002;40:3115–20.
Walker P, White D. Pulmonary disease. Med clin North Am. 1996;80:1337–62.
Attia EF, Pho Y, Nhem S, Sok C, By B, Phann D, et al. Tuberculosis and other bacterial co-infection in Cambodia: A single center retrospective cross-sectional study. BMC Pulm Med. 2019;19:1–7.
Langbang A, Deka N, Rahman H, Kalita D. A Study on Bacterial Pathogens causing Secondary Infections in Patients Suffering from Tuberculosis and their Pattern of Antibiotic Sensitivity. Int J Curr Microbiol Appl Sci. 2016;5:197–203.
Ngekeng S, Pokam B, Meriki H, Njunda A, Assob J, Ane-Anyangwe I. High Prevalence of Bacterial Pathogens in Sputum of Tuberculosis Suspected Patients in Buea. Br Microbiol Res J. 2015;11:1–8.
Iliyasu G, Mohammad AB, Yakasai AM, Dayyab FM, Oduh J, Habib AG. Gram-negative bacilli are a major cause of secondary pneumonia in patients with pulmonary tuberculosis: Evidence from a cross-sectional study in a tertiary hospital in Nigeria. Trans R Soc Trop Med Hyg. 2018;112:252–4.
Davis. CP. Normal Flora. In: Medical Microbiology. 1996.
Adhikari S, Khadka S, Rana JC, Baniya S, Poudel S, Chapagain A, et al. Prevalence of β -Lactamase Producing Carbapenem-Resistant Enterobacteriaceae among the Patients Attending Bharatpur Hospital. Biosci Discov. 2019;10:64–71.
Bertrand X, Hocquet D. Antibiotic drug resistance: Causes and solutions. EJHP Pract. 2011;17.
Forbes BA, Sahm DF WA. Diagnostic microbiology. St Louis; 2007.
Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 24th informational Suppl (M100-S28) Wayne. 2016.
Hana J, Chena D, Lic S, Lia X, Zhoud WW, Zhangb B, et al. Antibiotic susceptibility of potentially probiotic Lactobacillus strains. Ital J Food Sci. 2015;27:282–9.
Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. Multidrug-resistant urinary tract isolates of Escherichia coli: Prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother. 2001;45:1402–6.
Parajuli NP, Maharjan P, Joshi G, Khanal PR. Emerging Perils of Extended Spectrum β -Lactamase Producing Enterobacteriaceae Clinical Isolates in a Teaching Hospital of Nepal. Biomed Res Int. 2016;2016.
Samaha-Kfoury JN, Araj GF. Recent developments in lactamases and extended spectrum lactamases. BMJ. 2003;327:1209–13.
Nazi SA, Campus G. Prevalence and antibiogram pattern of pseudomonas species causing secondary infections among patients of pulmonary tuberculosis. IntI Chem Pharm Med J. 2005;2:231–7.
Chevalier S, Bouffartigues E, Bodilis J, Maillot O, Lesouhaitier O, Feuilloley MGJ, et al. Structure, function and regulation of Pseudomonas aeruginosa porins. FEMS Microbiol Rev. 2017;41:698–722.
Akingbade OA, Ogiogwa JI, Okerentugba PO, Innocent-Adiele H, Nwanze J, Okonko I, et al. Prevalence and Antibiotic Susceptibility Pattern of Bacterial Agents Involved In Lower Respiratory Tract Infections in Abeokuta, Ogun State, Nigeria. Rep Opin. 2012;4:25–30.
Egbagbe E, Mordi R. Aetiology of Lower Respiratory Tract Infection in Benin City, Nigeria. J Med Biomed Res. 2009;5:22–7.
Hasan A Z, Al-sulami A, Al-taee A. Gram Positive and Gram Negative Bacteria From Sputum of Clinically Tuberculosis Suspected Patients. Int J Curr Res. 2015;7:14289–91.
Egbe CA, Ndiokwere C, Omoregie R. Microbiology of lower respiratory tract infections in Benin city, Nigeria. Malaysian J Med Sci. 2011;18:27–31.
Sia JK, Rengarajan J. Immunology of Mycobacterium tuberculosis infections Jonathan. Microbiol Spectr. 2019;176:139–48.
Pokhrel BM, Koirala J, Mishra SK, Dahal RK, Khadga P, Tuladhar NR. Multidrug resistance and extended spectrum betalactamase producing strains causing lower respiratory tract and urinary tract infection. J Inst Med. 2006;28:19–27. www.jiom.com.np.
Thapa P, Bhandari D, Shrestha D, Parajuli H, Chaudhary P, Amatya J, et al. A hospital based surveillance of metallo-beta-lactamase producing gram negative bacteria in Nepal by imipenem-EDTA disk method. BMC Res Notes. 2017;10:1–6.
Ehondor TO, Ogefere HO, Ibadin EE. Detection of Metallo- β -Lactamase-Producing Gram-Negative Bacterial Isolates from Patients with Lower Respiratory Tract Infections in a Tertiary Hospital in Benin City, Nigeria. J Med Lab Sci. 2019;29:21–8.

Download PDF

Journal Publication

published 10 Nov, 2020

Read the published version in BMC Research Notes →

Editorial decision: Major revision
06 Oct, 2020
Review #1 received at journal
22 Sep, 2020
Reviewer #2 agreed at journal
20 Sep, 2020
Reviewer #1 agreed at journal
09 Aug, 2020
Editor assigned by journal
22 Jun, 2020
Reviewers invited by journal
22 Jun, 2020
Submission checks completed at journal
18 Jun, 2020
Editor invited by journal
18 Jun, 2020
First submitted to journal
16 Jun, 2020

You are reading this older preprint version

Read the latest preprint version →

Bacterial Etiology of Sputum from Tuberculosis Suspected Patients and Antibiogram of the Isolates

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Methods

Results

Discussion

Conclusions

Limitations

Abbreviations

Declarations

References

Supplementary Files

Status:

Journal Publication

Version 1